Edition:
United Kingdom

Intellipharmaceutics International Inc (IPCI.OQ)

IPCI.OQ on NASDAQ Stock Exchange Capital Market

0.36USD
20 Jul 2018
Change (% chg)

$-0.04 (-8.79%)
Prev Close
$0.40
Open
$0.38
Day's High
$0.40
Day's Low
$0.36
Volume
15,007
Avg. Vol
45,715
52-wk High
$2.86
52-wk Low
$0.32

Chart for

About

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of... (more)

Overall

Beta: 1.09
Market Cap(Mil.): $34.07
Shares Outstanding(Mil.): 31.02
Dividend: --
Yield (%): --

Financials

  IPCI.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.33 -- --
ROI: -1,305.65 15.07 14.61
ROE: -- 16.60 16.34

BRIEF-Intellipharmaceutics International Received Letter From Nasdaq To Delist Co's Securities

April 23 Intellipharmaceutics International Inc :

23 Apr 2018

BRIEF-Intellipharmaceutics Announces Us$ 1.8 mln Registered Direct Offering‍​

* INTELLIPHARMACEUTICS ANNOUNCES US$ 1.8 MILLION REGISTERED DIRECT OFFERING‍​

19 Mar 2018

BRIEF-Intellipharmaceutics Meets With FDA Regarding Oxycodone Er NDA Development Program

* INTELLIPHARMACEUTICS MEETS WITH FDA REGARDING OXYCODONE ER NDA DEVELOPMENT PROGRAM

09 Feb 2018

BRIEF-Intellipharmaceutics Provides Operational Update

* INTELLIPHARMACEUTICS - COMMERCIALIZATION OPPORTUNITIES FOR CO'S PRODUCT HAVE BEEN "CHALLENGING IN U.S. DUE TO EXTREMELY COMPETITIVE COST ENVIRONMENT"

24 Jan 2018

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $62.52 +0.01
Novartis AG (NOVN.S) CHF82.20 +1.24
Johnson & Johnson (JNJ.N) $125.85 -0.09
Pfizer Inc. (PFE.N) $37.33 -0.03

Earnings vs. Estimates